Skip to main content

XORTX Therapeutics Inc.

XRTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001729214

No open-market purchases or sales by XORTX Therapeutics Inc. insiders were filed in the last 90 days; 6 institutions reported holding it in 13F filings for Q2 2026, worth $92.8K in total; no superinvestor holds it.

Members of Congress who traded XRTX

No member of Congress has reported a trade in XORTX Therapeutics Inc. since 2020.

Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report.